Gregory Bacon will be attending this years SMi Group 10th annual Biosimilars conference, taking place on the 25 and 26 of September 2019. With growing demand for biosimilar drugs due to their cost-effectiveness, growing incidence of chronic diseases, and strategic collaborations, as well as the expiry dates of major patents fast approaching, the question is what can current biosimilar producing companies do to join this market to benefit the patients, physicians and investors?
At this conference:
- Hear about the current updates in patent laws provided by legal experts.
- Discuss the strategies being implemented to enhance the medical communication between stakeholders, physicians and patients
- Explore the landscape of biosimilar commercialisation in various international markets
- Review the recently approved drug delivery systems for biosimilars.
For more information see the SMi website.